{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T15:35:29Z","timestamp":1784475329577,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Adverse drug events (ADEs) often occur as a result of drug-drug interactions (DDIs). The use of data mining for detecting effects of drug combinations on ADE has attracted growing attention and interest, however, most studies focused on analyzing pairwise DDIs. Recent efforts have been made to explore the directional relationships among high-dimensional drug combinations and have shown effectiveness on prediction of ADE risk. However, the existing approaches become inefficient from both computational and illustrative perspectives when considering more than three drugs.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We proposed an efficient approach to estimate the directional effects of high-order DDIs through frequent itemset mining, and further developed a novel visualization method to organize and present the high-order directional DDI effects involving more than three drugs in an interactive, concise and comprehensive manner. We demonstrated its performance by mining the directional DDIs associated with myopathy using a publicly available FAERS dataset.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Directional effects of DDIs involving up to seven drugs were reported. Our analysis confirmed previously reported myopathy associated DDIs including interactions between fusidic acid with simvastatin and atorvastatin. Furthermore, we uncovered a number of novel DDIs leading to increased risk for myopathy, such as the co-administration of zoledronate with different types of drugs including antibiotics (ciprofloxacin, levofloxacin) and analgesics (acetaminophen, fentanyl, gabapentin, oxycodone). Finally, we visualized directional DDI findings via the proposed tool, which allows one to interactively select any drug combination as the baseline and zoom in\/out to obtain both detailed and overall picture of interested drugs.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We developed a more efficient data mining strategy to identify high-order directional DDIs, and designed a scalable tool to visualize high-order DDI findings. The proposed method and tool have the potential to contribute to the drug interaction research and ultimately impact patient health care.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Availability and implementation<\/jats:title>\n<jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/lishenlab.com\/d3i\/explorer.html\">http:\/\/lishenlab.com\/d3i\/explorer.html<\/jats:ext-link><\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12911-020-1053-z","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:03:57Z","timestamp":1584489837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Mining and visualizing high-order directional drug interaction effects using the FAERS database"],"prefix":"10.1186","volume":"20","author":[{"given":"Xiaohui","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Quinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"issue":"2","key":"1053_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/psp4.12267","volume":"7","author":"P Zhang","year":"2018","unstructured":"Zhang P, Wu HY, Chiang CW, Wang L, Binkheder S, Wang X, Zeng D, Quinney SK, Li L. Translational biomedical informatics and pharmacometrics approaches in the drug interactions research. CPT Pharmacometrics Syst Pharmacol. 2018; 7(2):90\u2013102.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"2","key":"1053_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/cpt.914","volume":"103","author":"CW Chiang","year":"2018","unstructured":"Chiang CW, Zhang P, Wang X, Wang L, Zhang S, Ning X, Shen L, Quinney SK, Li L. Translational high-dimensional drug interaction discovery and validation using health record databases and pharmacokinetics models. Clin Pharmacol Ther. 2018; 103(2):287\u2013295.","journal-title":"Clin Pharmacol Ther"},{"key":"1053_CR3","doi-asserted-by":"publisher","unstructured":"Ning X, Shen L, Li L. Predicting high-order directional drug-drug interaction relations. https:\/\/doi.org\/10.1109\/ichi.2017.76.","DOI":"10.1109\/ichi.2017.76"},{"issue":"10","key":"1053_CR4","doi-asserted-by":"publisher","first-page":"1701881","DOI":"10.1126\/sciadv.1701881","volume":"3","author":"M Cokol","year":"2017","unstructured":"Cokol M, Kuru N, Bicak E, Larkins-Ford J, Aldridge BB. Efficient measurement and factorization of high-order drug interactions in mycobacterium tuberculosis. Sci Adv. 2017; 3(10):1701881.","journal-title":"Sci Adv"},{"issue":"125","key":"1053_CR5","doi-asserted-by":"publisher","first-page":"20160800","DOI":"10.1098\/rsif.2016.0800","volume":"13","author":"Casey Beppler","year":"2016","unstructured":"Beppler C, Tekin E, Mao Z, White C, McDiarmid C, Vargas E, Miller JH, Savage VM, Yeh PJ. Uncovering emergent interactions in three-way combinations of stressors. J R Soc Interface. 2016; 13(125). https:\/\/doi.org\/10.1098\/rsif.2016.0800.","journal-title":"Journal of The Royal Society Interface"},{"issue":"2","key":"1053_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/psp4.12277","volume":"7","author":"L Li","year":"2018","unstructured":"Li L. Reverse translational pharmacology research is driven by big data. CPT Pharmacometrics Syst Pharmacol. 2018; 7(2):63\u20134.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"5","key":"1053_CR7","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1109\/JBHI.2018.2874533","volume":"23","author":"Danai Chasioti","year":"2019","unstructured":"Chasioti D, Yao X, Zhang P, Lerner S, Quinney SK, Ning X, Li L, Shen L. Mining directional drug interaction effects on myopathy using the FAERS database. J Biomed Health Inform IEEE. 2018:1\u20131. https:\/\/doi.org\/10.1109\/jbhi.2018.2874533.","journal-title":"IEEE Journal of Biomedical and Health Informatics"},{"issue":"5","key":"1053_CR8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1124\/dmd.115.067447","volume":"44","author":"H Eng","year":"2016","unstructured":"Eng H, Scialis RJ, Rotter CJ, Lin J, Lazzaro S, Varma MV, Di L, Feng B, West M, Kalgutkar AS. The antimicrobial agent fusidic acid inhibits organic anion transporting polypeptide\u2013mediated hepatic clearance and may potentiate statin-induced myopathy. Drug Metab Dispos. 2016; 44(5):692\u20139.","journal-title":"Drug Metab Dispos"},{"issue":"125","key":"1053_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1126\/scitranslmed.3003377","volume":"4","author":"NP Tatonetti","year":"2012","unstructured":"Tatonetti NP, Ye PP, Daneshjou R, Altman RB. Data-Driven Prediction of Drug Effects and Interactions. Sci Transl Med. 2012; 4(125):125\u201331.","journal-title":"Sci Transl Med"},{"issue":"10","key":"1053_CR10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s40264-015-0314-8","volume":"38","author":"Y Li","year":"2015","unstructured":"Li Y, Ryan PB, Wei Y, Friedman C. A method to combine signals from spontaneous reporting systems and observational healthcare data to detect adverse drug reactions. Drug Saf. 2015; 38(10):895\u2013908.","journal-title":"Drug Saf"},{"issue":"D1","key":"1053_CR11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/nar\/gkv1075","volume":"44","author":"M Kuhn","year":"2015","unstructured":"Kuhn M, Letunic I, Jensen LJ, Bork P. The SIDER database of drugs and side effects. Nucleic Acids Res. 2015; 44(D1):1075\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1053_CR12","first-page":"04","volume":"10","author":"P Kotian","year":"2016","unstructured":"Kotian P, Boloor A, Sreenivasan S. Study of adverse effect profile of parenteral zoledronic acid in female patients with osteoporosis. J Clin Diagn Res. 2016; 10(1):04\u20136.","journal-title":"J Clin Diagn Res"},{"issue":"2","key":"1053_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40261-012-0041-1","volume":"33","author":"P Sieber","year":"2013","unstructured":"Sieber P, Lardelli P, Kraenzlin CA, Kraenzlin ME, Meier C. Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice. Clin Drug Investig. 2013; 33(2):117\u201322.","journal-title":"Clin Drug Investig"},{"issue":"1","key":"1053_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13256-016-1004-6","volume":"10","author":"F John","year":"2016","unstructured":"John F, Oluronbi R, Pitchumoni CS. Levofloxacin-induced rhabdomyolysis: a case report. J Med Case Rep. 2016; 10(1):235.","journal-title":"J Med Case Rep"},{"issue":"1","key":"1053_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1345\/aph.1E285","volume":"39","author":"SH Hsiao","year":"2005","unstructured":"Hsiao SH, Chang CM, Tsao CJ, Lee YY, Hsu MY, Wu TJ. Acute rhabdomyolysis associated with ofloxacin\/levofloxacin therapy. Ann Pharmacother. 2005; 39(1):146\u20139.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"1053_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/hdi.12458","volume":"21","author":"MS Choi","year":"2017","unstructured":"Choi MS, Jeon H, Kim HS, Jang BH, Lee YH, Park HS, Kim H, Jin DC. A case of gabapentin-induced rhabdomyolysis requiring renal replacement therapy. Hemodial Int. 2017; 21(1):4\u20138.","journal-title":"Hemodial Int"},{"issue":"7","key":"1053_CR17","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1345\/aph.1K077","volume":"41","author":"M Tuccori","year":"2007","unstructured":"Tuccori M, Lombardo G, Lapi F, Vannacci A, Blandizzi C, Del Tacca M. Gabapentin-induced severe myopathy. Ann Pharmacother. 2007; 41(7):1301\u20135.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"1053_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/096032718500400109","volume":"4","author":"PG Blain","year":"1985","unstructured":"Blain PG, Lane RJ, Bateman DN, Rawlins MD. Opiate-induced rhabdomyolysis. Hum Toxicol. 1985; 4(1):71\u20134.","journal-title":"Hum Toxicol"},{"issue":"10","key":"1053_CR19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1034\/j.1398-9995.1999.00983.x","volume":"54","author":"DA Moneret-Vautrin","year":"1999","unstructured":"Moneret-Vautrin DA, Morisset M, Humbert JC, Beaudouin E, Tupin N, Plantier L. Acetaminophen-induced rhabdomyolysis. Allergy. 1999; 54(10):1115\u20136.","journal-title":"Allergy"},{"issue":"5","key":"1053_CR20","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1519\/JSC.0000000000001824","volume":"31","author":"BD McKay","year":"2017","unstructured":"McKay BD, Yeo NM, Jenkins NDM, Miramonti AA, Cramer JT. Exertional rhabdomyolysis in a 21-year-old healthy woman: A case report. J Strength Cond Res. 2017; 31(5):1403\u201310.","journal-title":"J Strength Cond Res"},{"issue":"4","key":"1053_CR21","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1592\/phco.27.4.608","volume":"27","author":"H Nelson","year":"2007","unstructured":"Nelson H, Katz D, Dunn T, Singh G, Voigt M, Whitaker E, Thomsen D. Rhabdomyolysis and necrotic bowel after acetaminophen and ibuprofen overdose. Pharmacotherapy. 2007; 27(4):608\u201312.","journal-title":"Pharmacotherapy"},{"issue":"7","key":"1053_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.nmd.2018.04.011","volume":"28","author":"T Kumutpongpanich","year":"2018","unstructured":"Kumutpongpanich T, Owattanapanich W, Tanboon J, Nishino I, Boonyapisit K. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance (slonm-mgus): An alternative treatment using cyclophosphamide-thalidomide-dexamethasone (ctd) regimen. Neuromuscul Disord. 2018; 28(7):610\u20133.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"1053_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1468-3083.2008.02766.x","volume":"23","author":"MY Wu","year":"2009","unstructured":"Wu MY, Hong JB, Yang CC, Hu SL, Liao YH. Scleromyxedema with myopathy was successfully treated by thalidomide. J Eur Acad Dermatol Venereol. 2009; 23(2):189\u201390.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1053_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jbspin.2010.02.025","volume":"78","author":"RM Pereira","year":"2011","unstructured":"Pereira RM, Freire de Carvalho J. Glucocorticoid-induced myopathy. Joint Bone Spine. 2011; 78(1):41\u20134.","journal-title":"Joint Bone Spine"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-020-1053-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12911-020-1053-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-020-1053-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:19:03Z","timestamp":1616026743000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-020-1053-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":24,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["1053"],"URL":"https:\/\/doi.org\/10.1186\/s12911-020-1053-z","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"18 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study analyzed de-identified and publicly available FAERS data. It has been determined by the University of Pennsylvania Institutional Review Board (IRB) that it meets eligibility criteria for IRB review exemption authorized by 45 CFR 46.104, category #4.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}